JPMorgan Chase & Co’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-535,498
| Closed | -$10.1M | – | 5018 |
|
|
2019
Q3 | $10.1M | Buy |
535,498
+304,759
| +132% | +$5.75M | ﹤0.01% | 1791 |
|
|
2019
Q2 | $2.61M | Sell |
230,739
-9,828
| -4% | -$111K | ﹤0.01% | 2527 |
|
|
2019
Q1 | $3.28M | Sell |
240,567
-15,573
| -6% | -$213K | ﹤0.01% | 2362 |
|
|
2018
Q4 | $2.63M | Sell |
256,140
-14,232
| -5% | -$146K | ﹤0.01% | 2497 |
|
|
2018
Q3 | $4.5M | Sell |
270,372
-26,065
| -9% | -$434K | ﹤0.01% | 2303 |
|
|
2018
Q2 | $4.68M | Sell |
296,437
-53,204
| -15% | -$840K | ﹤0.01% | 2282 |
|
|
2018
Q1 | $4.44M | Sell |
349,641
-70,964
| -17% | -$901K | ﹤0.01% | 2283 |
|
|
2017
Q4 | $4.82M | Buy |
420,605
+905
| +0.2% | +$10.4K | ﹤0.01% | 2274 |
|
|
2017
Q3 | $4.81M | Buy |
419,700
+184,097
| +78% | +$2.11M | ﹤0.01% | 2196 |
|
|
2017
Q2 | $2.7M | Buy |
235,603
+228,205
| +3,085% | +$2.61M | ﹤0.01% | 2462 |
|
|
2017
Q1 | $155K | Sell |
7,398
-45,956
| -86% | -$963K | ﹤0.01% | 3590 |
|
|
2016
Q4 | $1.11M | Buy |
53,354
+52,402
| +5,504% | +$1.09M | ﹤0.01% | 2948 |
|
|
2016
Q3 | $31K | Sell |
952
-344,869
| -100% | -$11.2M | ﹤0.01% | 3674 |
|
|
2016
Q2 | $8.64M | Sell |
345,821
-3,661
| -1% | -$91.4K | ﹤0.01% | 1717 |
|
|
2016
Q1 | $8.56M | Buy |
349,482
+35,883
| +11% | +$879K | ﹤0.01% | 1672 |
|
|
2015
Q4 | $10.4M | Buy |
313,599
+89,681
| +40% | +$2.96M | ﹤0.01% | 1583 |
|
|
2015
Q3 | $7.34M | Buy |
+223,918
| New | +$7.34M | ﹤0.01% | 1754 |
|